Proteogenomic analysis of melanoma brain metastases from distinct anatomical sites identifies pathways of metastatic progression

Melanoma brain metastases (MBM) portend a grim prognosis and can occur in up to 40% of melanoma patients. Genomic characterization of brain metastases has been previously carried out to identify potential mutational drivers. However, to date a comprehensive multi-omics approach has yet to be used to...

Descripción completa

Detalles Bibliográficos
Autores principales: Taylor, Erin M., Byrum, Stephanie D., Edmondson, Jacob L., Wardell, Christopher P., Griffin, Brittany G., Shalin, Sara C., Gokden, Murat, Makhoul, Issam, Tackett, Alan J., Rodriguez, Analiz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7487560/
https://www.ncbi.nlm.nih.gov/pubmed/32891176
http://dx.doi.org/10.1186/s40478-020-01029-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7487560/
https://www.ncbi.nlm.nih.gov/pubmed/32891176
http://dx.doi.org/10.1186/s40478-020-01029-x

Ejemplares similares